Clinical trial
Exenatide and Metformin Therapy in Overweight Women With PCOS
NCT00344851 · Metabolic Center of Louisiana Research Foundation, Other · Completed
Key facts
| NCT number | NCT00344851 |
|---|---|
| Title | Exenatide and Metformin Therapy in Overweight Women With PCOS |
| Official title | Comparison of the Effects of Monotherapy With Exenatide or Metformin to Combined Exenatide and Metformin Therapy on Menstrual Cyclicity in Overweight Women With Polycystic Ovary Syndrome |
| Lead sponsor | Metabolic Center of Louisiana Research Foundation, Other |
| Collaborators | Amylin Pharmaceuticals, LLC. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Polycystic Ovary Syndrome |
| Intervention type | Drug |
| Interventions | metformin, exenatide or combined (metformin & exenatide ) |
| Enrollment | 60 |
| Start date | Jun 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jun 27, 2006 |
| Last update posted | Jul 11, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: